CN104998129A - 一种用于蛛网膜下腔出血的中药制剂及其制备方法 - Google Patents
一种用于蛛网膜下腔出血的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104998129A CN104998129A CN201510525255.4A CN201510525255A CN104998129A CN 104998129 A CN104998129 A CN 104998129A CN 201510525255 A CN201510525255 A CN 201510525255A CN 104998129 A CN104998129 A CN 104998129A
- Authority
- CN
- China
- Prior art keywords
- radix
- blood
- preparation
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 title claims abstract description 25
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000628997 Flos Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 241000180649 Panax notoginseng Species 0.000 claims description 12
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 238000001802 infusion Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000571 coke Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 87
- 210000004369 blood Anatomy 0.000 abstract description 86
- 230000000694 effects Effects 0.000 abstract description 40
- 230000023597 hemostasis Effects 0.000 abstract description 17
- 230000005906 menstruation Effects 0.000 abstract description 15
- 230000001939 inductive effect Effects 0.000 abstract description 13
- 238000001816 cooling Methods 0.000 abstract description 12
- 230000001914 calming effect Effects 0.000 abstract description 7
- 210000002216 heart Anatomy 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 206010067482 No adverse event Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 abstract description 3
- 241001071917 Lithospermum Species 0.000 abstract description 3
- 235000006533 astragalus Nutrition 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 241001313857 Bletilla striata Species 0.000 abstract description 2
- 240000003690 Callicarpa japonica Species 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 241000112528 Ligusticum striatum Species 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 235000015456 Japanese beauty berry Nutrition 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 32
- 230000017531 blood circulation Effects 0.000 description 29
- 239000000796 flavoring agent Substances 0.000 description 25
- 235000019634 flavors Nutrition 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 21
- 229940079593 drug Drugs 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 19
- 206010030113 Oedema Diseases 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 11
- 206010001928 Amenorrhoea Diseases 0.000 description 11
- 208000006820 Arthralgia Diseases 0.000 description 11
- 231100000540 amenorrhea Toxicity 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 10
- 230000035619 diuresis Effects 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000002175 menstrual effect Effects 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 208000005171 Dysmenorrhea Diseases 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 208000001780 epistaxis Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 208000019255 Menstrual disease Diseases 0.000 description 7
- 206010027514 Metrorrhagia Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 208000006750 hematuria Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 208000034507 Haematemesis Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000035861 hematochezia Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010021118 Hypotonia Diseases 0.000 description 4
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 210000002330 subarachnoid space Anatomy 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000003773 Meningism Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 210000004289 cerebral ventricle Anatomy 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 229960003883 furosemide Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000001286 intracranial vasospasm Diseases 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 238000009593 lumbar puncture Methods 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- -1 r Species 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000018316 severe headache Diseases 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- 241000125147 Aethusa cynapium Species 0.000 description 1
- 241001278836 Agrimonia pilosa Species 0.000 description 1
- 235000000641 Agrimonia pilosa Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000130784 Arnebia euchroma Species 0.000 description 1
- 241001050829 Arnebia guttata Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241001136615 Callicarpa dichotoma Species 0.000 description 1
- 235000017595 Callicarpa japonica Nutrition 0.000 description 1
- 241001497937 Callicarpa pedunculata Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 240000007171 Imperata cylindrica Species 0.000 description 1
- 206010021666 Increased intracranial pressure and hydrocephalus Diseases 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000003271 Leonurus japonicus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241000729196 Lycopus lucidus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000002924 Platycladus orientalis Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000009235 Rubia cordifolia Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 208000002667 Subdural Hematoma Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000576 arachnoid Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000003788 cerebral perfusion Effects 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 206010019465 hemiparesis Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000000701 subdural space Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于蛛网膜下腔出血的中药制剂,它是以川牛膝、丹参、仙鹤草、茜草、紫草、牡丹皮、白芨、三七、红花、益母草、泽兰、棕榈碳、紫珠、藕节、黄芪、当归、川芎、熟地黄、白芍、白茅根、茯苓、炒白术、侧柏叶、炙甘草为原料,属于中药发明领域。根据每味中药的不同特性,以洗净切块预处理后,按比例配制,经特殊方法制作,具有活血祛瘀、通经止痛、补气宁心、凉血止血的作用,本发明产品组合及制作方法独特,经临床验证,该药治疗效果显著,治疗周期短,价格低廉,无不良反应和任何毒副作用,具有广阔的市场应用前景。
Description
技术领域
本发明涉及一种中药制剂,具体涉及一种用于蛛网膜下腔出血的中药制剂,本发明还涉及该中药制剂的制备方法。
背景技术
蛛网膜下腔出血(subarachnoid hemorrhage,SAH)指脑底部或脑表面的病变血管破裂,血液直接流入蛛网膜下腔引起的一种临床综合征,又称为原发性蛛网膜下腔出血,约占急性脑卒中的10%,是一种非常严重的常见疾病。世界卫生组织调查显示中国发病率约为2.0/10万人年,亦有报道为每年6-20/10万人。还可见因脑实质内 ,脑室出血,硬膜外或硬膜下血管破裂,血液穿破脑组织流入蛛网膜下腔,称为继发性蛛网膜下腔出血。其发病原因为血液流入蛛网膜下腔,使脑脊液血染,脑表面呈紫红色,脑底部、脑池、脑沟染色尤甚。血液可流入脊髓蛛网膜下腔,也可逆流入脑室系统或破人硬脑膜下腔,形成硬脑膜下血肿。出血量多时,可积聚成血块或侵入脑实质内压迫脑组织。血块也可阻塞脑室系统或蛛网膜下腔通路或脑蛛网膜颗粒,引起颅内压增高和脑积水。血液的分解产物可引起脑血管痉挛。颅内压增高、脑血管痉挛又可使脑血流量、区域脑耗氧量和脑灌注压降低,从而加重脑缺血缺氧损害。严重病人因下丘脑功能紊乱导致心肌损害、肺水肿、胃肠道出血和水电解质紊乱。
目前,蛛网膜下腔出血尚无特效疗法。甘露醇、呋塞米和人血白蛋白等有一定疗效。严重者需要立刻进行手术治疗。但长期或短时间使用这些药物进行治疗,可引起多毛、水肿、恶心、呕吐、头晕,便秘等等一系列副作用症状,并产生了的依赖性,停药后原发病变反跳加重与继发的副作用,可使患者产生很大的痛苦,治疗过程反反复复,效果不明显,费用高等,给患者的造成较大的心里压力和病痛压力。
发明内容
本发明的目的在于提供一种用于蛛网膜下腔出血的中药制剂,该中药制剂对于治疗蛛网膜下腔出血具有治疗效果显著,治愈时间短,价格低廉,无不良反应和副毒作用的特点。
发明人在多年的临床医疗实践中,根据该病症的发展规律,以及中药的配伍原则,并通过大量的临床验证,反复探索总结出用于治疗蛛网膜下腔出血的中药制剂的新配方。本发明具有治疗效果显著,治愈时间短,价格低廉,无不良反应和副毒作用的特点。
本发明中药物的作用:
其中:
川牛膝:为四川苋科植物牛膝Achyranthes bidentata Blume. 的干燥根。性味:苦、酸,平。归肝、肾经。功效: 逐瘀通经,通利关节,利尿通淋。用于经闭症瘕,胞衣不下,关节痹痛,足痿筋挛,尿血血淋,跌扑损伤。《四川中药志》中记载:祛风利湿,通经散血。治寒湿腰腿骨痛,足痿筋挛,妇女经闭及症瘕,淋病,尿血,阴痿、失溺。
丹参:为唇形科植物丹参Salvia miltiorrhiza Bunge. 的干燥根及根茎。性味:苦,微寒。归心、肝经。功效:祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。《滇南本草》中记载:补心定志,安神宁心。治健忘怔冲,惊悸不寐。
仙鹤草:为蔷薇科植物龙牙草Agrimonia pilosa Ledeb. 的干燥地上部分。性味:苦、涩,平。归心、肝经。功效:收敛止血,截疟,止痢,解毒。用于咳血,吐血,崩漏下血,疟疾,血痢,脱力劳伤,痈肿疮毒,阴痒带下。《百草镜》:下气活血,理百病,散痞满;跌扑吐血,血崩,痢,肠风下血。
紫草:为紫草科植物新疆紫草Arnebia euchroma (Royle)Johnst. 、紫草Lithospermum erythrorhizon Sieb. et Zucc. 或内蒙紫草Arnebia guttata Bunge 的干燥根。性味:甘、咸,寒。归心、肝经。功效:凉血,活血,解毒透疹。用于血热毒盛,斑疹紫黑,麻疹不透,疮疡,湿疹,水火烫伤。《纲目》中记载:治斑疹、痘毒,活血凉血,利大肠。
牡丹皮:为毛茛科植物牡丹Paeonia suffruticosa Andr.的干燥根皮。性味:苦、辛,微寒。归心、肝、肾经。功效:清热凉血,活血化瘀。用于温毒发斑,吐血衄血,夜热早凉,无汗骨蒸,经闭痛经,痈肿疮毒,跌扑伤痛。《本经》中记载:主寒热,中风瘈疭、痉、惊痫邪气,除症坚瘀血留舍肠胃,安五脏,疗痈疮。
白及:为兰科植物白及Bletilla striata(Thunb.) Reichb. f.的干燥块茎。性味:苦、甘、涩,微寒。归肺、肝、胃经。功效:收敛止血,消肿生肌。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。《药性论》中记载:治结热不消,主阴下痿,治面上皯疱,令人肌滑。
三七:为五加科植物三七Panax notoginseng (Burk.)F. H. Chen的干燥根。性味:甘、微苦,温。归肝、胃经。功效:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹剌痛,跌扑肿痛。《玉揪药解》中记载:"和营止血,通脉行瘀,行瘀血而敛新血。
红花:为菊科植物红花Carthamus tinctorius L.的干燥花。性味:辛,温。归心、肝经。功效:活血通经,散瘀止痛。用于经闭,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。《纲目》:活血,润燥,止痛,散肿,通经。
益母草:为唇形科植物益母草Leonurus japonicus Houtt. 的新鲜或干燥地上部分。性味:苦、辛,微寒。归肝、心包经。功效:活血调经,利尿消肿。用于月经不调,痛经,经闭,恶露不尽,水肿尿少;急性肾炎水肿。
泽兰:为唇形科植物毛叶地瓜儿苗Lycopus lucidus Turcz. var.hirtus Regel的干燥地上部分。夏、秋季茎叶茂盛时采割,晒干。性味:苦、辛,微温。归肝、脾经。功效:活血化瘀,行水消肿。用于月经不调,经闭,痛经,产后瘀血腹痛,水肿。《日华子本草》中记载:通九窍,利关脉,养血气,破宿血,消症瘕。
黄芪:为豆科植物蒙古黄芪 Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.)Hsiao 或膜荚黄芪 Astragalus membranaceus (Fisch.) Bge.的干燥根。性味:甘,温。归肺、脾经。功效:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
当归:为伞形科植物当归Angelica sinensis (Oliv.) Diels 的干燥根。性味:甘、辛,温。归肝、心、脾经。功效:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。《别录》中记载:温中止痛,除客血内塞,中风痉、汗不出,湿痹,中恶客气、虚冷,补五藏,生肌肉。
川芎:为伞形科植物川芎Ligusticum chuanxiong Hort.(或Ligusticum wallichii Franch.)的干燥根茎。性味:辛,温。归肝、胆、心包经。功效:活血行气,祛风止痛。用于月经不调,经闭痛经,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。《日华子本草》中记载:治一切风,一切气,一切劳损,一切血,补五劳,壮筋骨,调众脉,破癥结宿血,养新血,长肉,鼻洪,吐血及溺血,痔瘘,脑痈发背,瘰疬瘿赘,疮疥,及排脓消瘀血。
熟地黄:为生地黄的炮制加工品。性味:甘,微温。归肝、肾经。功能主治:滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。《珍珠囊》中记载:大补血虚不足,通血脉,益气力。
白芍:为毛茛科植物芍药Paeonia lactiflora Pall. 的干燥根。性味:苦、酸,微寒。归肝、脾经。功效:平肝止痛,养血调经,敛阴止汗。用于头痛眩晕,胁痛,腹痛,四肢挛痛,血虚萎黄,月经不调,自汗,盗汗。《本经》中记载:主邪气腹痛,除血痹,破坚积,治寒热疝瘕,止痛,利小便,益气。
白茅根:为禾本科植物白茅Imperata cylindrica Beauv. var. major (Nees)C. E. Hubb. 的干燥根茎。性味:甘,寒。归肺、胃、膀胱经。
功效:凉血止血,清热利尿。用于血热吐血,衄血,尿血,热病烦渴,黄疸,水肿,热淋涩痛;急性肾炎水肿。
茯苓:为多孔菌科真菌茯苓 Poria cocos (Schw.) Wolf 的干燥菌核。性味:甘、淡,平。归心、肺、脾、肾经。功效:利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。《日华子本草》中记载:补五劳七伤,安胎,暖腰膝,开心益智,止健忘。
炒白术:为菊科植物白术Atractylodes macrocephala Koidz.的干燥根茎的炮制品。性味:苦、甘,温。归脾、胃经。功效:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。《本经》中记载:主风寒湿痹,死肌,痉,疸,止汗,除热消食。
侧柏叶:为柏科植物侧柏Platycladus orientalis (L.)Franco 的干燥枝梢及叶。性味:苦、涩,寒。归肺、肝、脾经。功效:凉血止血,生发乌发。用于吐血衄血,咯血,便血,崩漏下血,血热脱发,须发早白。《本草正》在记载:善清血凉血,去湿热湿痹,骨节疼痛。捣烂可敷火丹,散痄腮肿痛热毒。
炙甘草:为甘草的炮制加工品。性味:甘,平。归心、肺、脾、胃经 。功效:补脾和胃,益气复脉。用于脾胃虚弱,倦怠乏力,心动悸,脉结代。
茜草:为茜草科植物茜草Rubia cordifolia L. 的干燥根及根茎。性味:苦,寒。归肝经。功效:凉血,止血,祛瘀,通经。用于吐血,衄血,崩漏,外伤出血,经闭瘀阻,关节痹痛,跌扑肿痛。
棕榈皮:为棕榈科植物棕榈的叶鞘纤维。 性味:苦涩,平。归肝、脾经。功效:收涩止血。治吐血,衄血,便血,血淋,尿血,下痢,血崩,带下,金疮,疥癣。《海药本草》中记载:主金疮疥癣,生肌止血,并宜烧灰使用。
紫珠:为马鞭草科紫珠属植物杜虹花Callicarpa pedunculata R. Brown及白棠子树C. dichotoma (Lour.)K. Koch.,以茎、叶及根入药。性味:苦、涩,平。功效:止血,散瘀,消炎。用于衄血,咯血,胃肠出血,子宫出血,上呼吸道感染,扁桃体炎,肺炎,支气管炎;外用治外伤出血,烧伤。《本草拾遗》中 记载:解诸毒物,痈疽,喉痹,毒肿,下痿,蛇虺虫螫,狂犬毒,并煮汁服;亦煮汁洗疮肿,除血长肤。
藕节:为睡莲科植物莲Nelumbo nucifera Gaertn. 的干燥根茎节部。秋、冬二季采挖根茎(藕),切取节部,洗净,晒干,除去须根。性味:甘、涩,平。归肝、肺、胃经。功效:止血,消瘀。用于吐血,咯血,尿血,崩漏。《纲目拾遗》中记载:藕节粉:开膈,补腰肾,和血脉,散瘀血,生新血;产后及吐血者食之尤佳。
本发明的方解是:川牛膝逐瘀通经、通利关节,丹参祛瘀止痛、活血通经,茜草凉血止血、祛瘀通经,紫草凉血活血、解毒透疹,牡丹皮清热凉血、活血化瘀,红花活血通经、散瘀止痛,益母草活血调经、利尿消肿,泽兰活血化瘀、行水消肿,当归补血活血、调经止痛,川芎活血行气、祛风止痛,以上十味药作为方中君药,均归肝经,具有活血祛瘀、通经止痛的作用。中医学认为,本病的形成多邪毒外侵,内伏血分,致使络脉受损而生。因血虚肝旺、气血凝滞以致疼痛剧烈而引发本病。所以活血祛瘀、通经止痛是治疗蛛网膜下腔出血的基础,以上十味药均为君药,首先从根本上活血祛瘀、通经止痛,使病症得到根本的控制。黄芪补气固表、利尿托毒,熟地黄滋阴补血、益精填髓,白芍平肝止痛、养血调经,茯苓利水渗湿、健脾宁心,炒白术健脾益气、燥湿利水,以上五味药为方中臣药,中医认为本病的引发是自身机体抗力减弱,导致机体内在受到外邪入侵,在血管部门导致血液运行不畅而引发本病。一方面辅助君药活血祛瘀、通经止痛的功效;另一方面作为臣药具有补气益气、调经宁心的功效。仙鹤草收敛止血,白芨收敛止血、消肿生肌,三七散瘀止血、消肿定痛,棕榈碳收涩止血,紫珠止血散瘀,藕节止血消瘀,白茅根凉血止血、清热利尿,侧柏叶凉血止血、生发乌发, 以上八味药作为佐药,从病理上治疗引起蛛网膜下腔出血的诱因,作为佐药既能促进君臣二药的活血祛瘀、通经止痛的功效,又能反佐君臣二药促进机体凉血止血、收敛消肿的作用。炙甘草作为方中使药,具有调和诸药、调和药味的作用,此方诸药合用,君臣协力,佐使共辅,具有活血祛瘀、通经止痛、补气宁心、凉血止血的功效,能够有效治疗蛛网膜下腔出血。
本发明另一个重要特点是该中药制剂含有丰富的营养成分,富含氨基酸有17种以上,其中人体必需氨基酸有苏氨酸、缬氨酸、蛋氨酸、异亮氨酸、亮氨酸、赖氨酸和苯丙氨酸,含有人体必需的微量元素有铁、铬、铜、硼、锰、锶、和锌,另含钙、钾、镁、磷几种人体宏量元素。以上营养成分都是人体必需物质,能有效增强人体免疫力。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:川牛膝16-20g、丹参18-22g、仙鹤草28-32g、茜草13-17g、紫草13-17g、牡丹皮13-17g、白芨10-14g、三七10-14g、红花7-11g、益母草18-22g、泽兰13-17g、棕榈碳13-17g、紫珠10-14g、藕节13-17g、黄芪22-26g、当归13-17g、川芎10-14g、熟地黄16-20g、白芍13-17g、白茅根22-26g、茯苓13-17g、炒白术22-26g、侧柏叶10-14g、炙甘草4-8g。
其中优选为:川牛膝18g、丹参20g、仙鹤草30g、茜草15g、紫草15g、牡丹皮15g、白芨12g、三七12g、红花9g、益母草20g、泽兰15g、棕榈碳15g、紫珠12g、藕节15g、黄芪24g、当归15g、川芎12g、熟地黄18g、白芍15g、白茅根24g、茯苓15g、炒白术24g、侧柏叶12g、炙甘草6g。
一种用于蛛网膜下腔出血的中药制剂的制备方法如下:
步骤一:按本发明重量份配比,取三七,粉碎,过200目筛,备用;
步骤二:按本发明重量份配比,取净棕榈皮,置锅内,覆盖一口径稍小的锅,锅上粘贴白纸一张,于两锅接合处用黄泥严封,微火煅至白纸呈焦黄色停火,侯冷取出,粉碎,过200目筛,备用;
步骤三:按本发明重量份配比,取炒白术、炙甘草、熟地黄,粉碎,过200目筛,备用;
步骤四:按本发明重量配比,取川牛膝、丹参、茜草、白芨、紫珠、藕节、黄芪、白芍、白茅根、茯苓药材置于砂锅中,加入8倍体积的水,武火熬煮20-30分钟后,加入仙鹤草、紫草、牡丹皮、红花、益母草、泽兰、当归、川芎、侧柏叶,武火熬煮10-20分钟,转文火熬煮30~40分钟得滤液,反复熬煮三次合并所得滤液,备用;
步骤五:将步骤四所得滤液趁热冲服步骤一所得粉末,混合,搅匀,再与步骤二、三所得粉末混合,搅匀,既得本发明所述的治疗蛛网膜下腔出血的汤剂。
本发明使用方法:取汤剂,饭后一小时内服用,每天三次。
本发明药物具有活血祛瘀、通经止痛、补气宁心、凉血止血的作用,且止痛效果好,价格低廉,无毒副作用,使用方便,该中药制剂采用的方式治疗可以减少西药对患者身体的伤害,减轻患者的病痛, 据对临床240例患者观察统计,使用本发明药物一个疗程总有效率82.5%,两个疗程总有效率95%。
具体实施方式
实施例一:川牛膝18g、丹参20g、仙鹤草30g、茜草15g、紫草15g、牡丹皮15g、白芨12g、三七12g、红花9g、益母草20g、泽兰15g、棕榈碳15g、紫珠12g、藕节15g、黄芪24g、当归15g、川芎12g、熟地黄18g、白芍15g、白茅根24g、茯苓15g、炒白术24g、侧柏叶12g、炙甘草6g。
实施例二:川牛膝17g、丹参21g、仙鹤草31g、茜草17g、紫草14g、牡丹皮15g、白芨11g、三七13g、红花8g、益母草21g、泽兰14g、棕榈碳15g、紫珠11g、藕节14g、黄芪24g、当归15g、川芎12g、熟地黄18g、白芍16g、白茅根24g、茯苓16g、炒白术23g、侧柏叶13g、炙甘草7g。
实施例三:川牛膝19g、丹参21g、仙鹤草31g、茜草17g、紫草14g、牡丹皮14g、白芨11g、三七11g、红花9g、益母草21g、泽兰14g、棕榈碳14g、紫珠11g、藕节14g、黄芪23g、当归14g、川芎13g、熟地黄18g、白芍16g、白茅根23g、茯苓13g、炒白术23g、侧柏叶13g、炙甘草8g。
下面是患者使用本发明药物的临床统计资料:
一、一般资料
收治门诊患者240例,将患者随机分为观察组和对照组各30例,其中男性120例,女性120例,男女比例1:1,最大年龄76岁,最小年龄36岁,病程几个月到几年不等。两组患者年龄、性别、病程等各项基本资料基本相同,差异无统计学意义(P>0.05)。
二、 诊断标准
1、突发的背部或颈部疼痛,迅速出现截瘫。
2、并有膀胱功能障碍及脑膜刺激症状。
3、脑脊液呈血性。
三、治疗方法:
1、观察组按照本发明药物实施例一,称取原料药按发明实施方法治疗,取汤剂,饭后一小时内服用,每天三次。7天为一个疗程。
2、对照组采用常规西药呋塞米治疗,7天为一疗程。
四、疗效评定标准:
1、治愈:症状及体征消失,脑脊液恢复正常。
2、好转:症状及体征改善。
3、无效:经治疗1周以上,症状均不见好转者。
五、治疗结果统计:
对照组结果统计
使用该中药制剂两个疗程两组患者的疗效对比情况
其中:总有效率=治愈率+好转率
通过对比两组患者的治疗总有效率可以发现观察组明显高于对照组,由此说明,本发明中药在治疗蛛网膜下腔出血上具有良好的临床效果,能有效提高治疗的治愈率,效果显著,价格低廉,无不良反应和任何毒副作用,具有广阔的市场应用前景。
典型病例及疗效:
病例一、患者王某,女,66岁,青岛市人,2010年1月20日来我处就诊。突然剧烈头痛、呕吐,有意识障碍,有脑膜刺激征,腰穿脑脊液呈血性。诊断为蛛网膜下腔出血。经治疗疼痛缓解,但未治愈。遂来我处治疗,采用本发明实施例一中所制制剂,以及所选的制备方法,症状减退,用药5天后,头疼消失,恢复良好,继续用药6天,彻底治愈,电话随访半年未复发。
病例二、患者李某,男,52岁,山东临沂人。2010年5月14日来我处就诊,突然剧烈头痛、呕吐,伴有精神症状的意识障碍,伴有颅神经及轻偏瘫局灶体征,腰穿脑脊液呈血性,确诊为蛛网膜下腔出血。采用本发明实施例一中所制制剂,以及所选的制备方法,症状减退,头疼痛感稍有减轻,用药7天后,头疼痛消失,患处恢复良好,继续用药5天,彻底治愈,电话随访半年未复发。
Claims (4)
1.一种用于蛛网膜下腔出血的中药制剂,其特征在于,该中药制剂是由以下重量份的药物制成:川牛膝16-20g、丹参18-22g、仙鹤草28-32g、茜草13-17g、紫草13-17g、牡丹皮13-17g、白芨10-14g、三七10-14g、红花7-11g、益母草18-22g、泽兰13-17g、棕榈碳13-17g、紫珠10-14g、藕节13-17g、黄芪22-26g、当归13-17g、川芎10-14g、熟地黄16-20g、白芍13-17g、白茅根22-26g、茯苓13-17g、炒白术22-26g、侧柏叶10-14g、炙甘草4-8g。
2. 根据权利要求1所述的用于蛛网膜下腔出血的中药制剂,其特征在于,由以下重量份的药物制成:川牛膝18g、丹参20g、仙鹤草30g、茜草15g、紫草15g、牡丹皮15g、白芨12g、三七12g、红花9g、益母草20g、泽兰15g、棕榈碳15g、紫珠12g、藕节15g、黄芪24g、当归15g、川芎12g、熟地黄18g、白芍15g、白茅根24g、茯苓15g、炒白术24g、侧柏叶12g、炙甘草6g。
3.根据权利要求1或2所述的用于蛛网膜下腔出血的中药制剂,其特征在于:所述中药制剂为汤剂。
4.一种用于蛛网膜下腔出血的中药制剂的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量份配比,取三七,粉碎,过200目筛,备用;步骤二:按本发明重量份配比,取净棕榈皮,置锅内,覆盖一口径稍小的锅,锅上粘贴白纸一张,于两锅接合处用黄泥严封,微火煅至白纸呈焦黄色停火,侯冷取出,粉碎,过200目筛,备用;步骤三:按本发明重量份配比,取炒白术、炙甘草、熟地黄,粉碎,过200目筛,备用;步骤四:按本发明重量配比,取川牛膝、丹参、茜草、白芨、紫珠、藕节、黄芪、白芍、白茅根、茯苓药材置于砂锅中,加入8倍体积的水,武火熬煮20-30分钟后,加入仙鹤草、紫草、牡丹皮、红花、益母草、泽兰、当归、川芎、侧柏叶,武火熬煮10-20分钟,转文火熬煮30~40分钟得滤液,反复熬煮三次合并所得滤液,备用;步骤五:将步骤四所得滤液趁热冲服步骤一所得粉末,混合,搅匀,再与步骤二、三所得粉末混合,搅匀,既得本发明所述的治疗蛛网膜下腔出血的汤剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510525255.4A CN104998129A (zh) | 2015-08-25 | 2015-08-25 | 一种用于蛛网膜下腔出血的中药制剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510525255.4A CN104998129A (zh) | 2015-08-25 | 2015-08-25 | 一种用于蛛网膜下腔出血的中药制剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104998129A true CN104998129A (zh) | 2015-10-28 |
Family
ID=54371165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510525255.4A Pending CN104998129A (zh) | 2015-08-25 | 2015-08-25 | 一种用于蛛网膜下腔出血的中药制剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104998129A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727033A (zh) * | 2016-03-30 | 2016-07-06 | 广州暨南生物医药研究开发基地有限公司 | 一种含艾叶的治疗自发性蛛网膜下腔出血症的药物制剂 |
| CN105833149A (zh) * | 2016-05-04 | 2016-08-10 | 张立杰 | 一种用于发作性睡病的中药制剂及其制备方法 |
| CN107468422A (zh) * | 2017-08-30 | 2017-12-15 | 苏州市苏真床垫有限公司 | 一种促进伤口愈合的护理垫 |
| CN109620922A (zh) * | 2019-01-28 | 2019-04-16 | 浴康中医保健养生(江苏)有限公司 | 一种用于治疗结节钙化灶的中药制剂及其制备方法 |
| CN111228443A (zh) * | 2020-03-26 | 2020-06-05 | 成都西南中医医院有限公司 | 治疗紫癜的中药组合物及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709404A (zh) * | 2005-06-21 | 2005-12-21 | 浙江杭州鑫富药业股份有限公司 | 一种防治中风疾病的中成药及其生产方法、用途 |
| CN101628054A (zh) * | 2009-08-02 | 2010-01-20 | 李述岩 | 一种治疗缺血性脑中风及其后遗症的药物 |
| CN101675948A (zh) * | 2008-09-18 | 2010-03-24 | 天津市中宝制药有限公司 | 治疗中风的中药组合物 |
-
2015
- 2015-08-25 CN CN201510525255.4A patent/CN104998129A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1709404A (zh) * | 2005-06-21 | 2005-12-21 | 浙江杭州鑫富药业股份有限公司 | 一种防治中风疾病的中成药及其生产方法、用途 |
| CN101675948A (zh) * | 2008-09-18 | 2010-03-24 | 天津市中宝制药有限公司 | 治疗中风的中药组合物 |
| CN101628054A (zh) * | 2009-08-02 | 2010-01-20 | 李述岩 | 一种治疗缺血性脑中风及其后遗症的药物 |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105727033A (zh) * | 2016-03-30 | 2016-07-06 | 广州暨南生物医药研究开发基地有限公司 | 一种含艾叶的治疗自发性蛛网膜下腔出血症的药物制剂 |
| CN105833149A (zh) * | 2016-05-04 | 2016-08-10 | 张立杰 | 一种用于发作性睡病的中药制剂及其制备方法 |
| CN107468422A (zh) * | 2017-08-30 | 2017-12-15 | 苏州市苏真床垫有限公司 | 一种促进伤口愈合的护理垫 |
| CN109620922A (zh) * | 2019-01-28 | 2019-04-16 | 浴康中医保健养生(江苏)有限公司 | 一种用于治疗结节钙化灶的中药制剂及其制备方法 |
| CN111228443A (zh) * | 2020-03-26 | 2020-06-05 | 成都西南中医医院有限公司 | 治疗紫癜的中药组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078520B (zh) | 一种治疗神经性头痛的中药制剂及其制备方法 | |
| CN103536758A (zh) | 一种治疗阴虚盗汗的中药组合物 | |
| CN106075276A (zh) | 一种用于治疗先兆流产的中药制剂及其制备方法 | |
| CN104998129A (zh) | 一种用于蛛网膜下腔出血的中药制剂及其制备方法 | |
| CN104940740A (zh) | 一种治疗多囊卵巢综合征的中药组合物及其制备方法 | |
| CN104825963A (zh) | 一种用于习惯性流产的中药制剂及其制备方法 | |
| CN104288424A (zh) | 一种治疗介入术后深静脉血栓的中药制剂及其制备方法 | |
| CN104225166A (zh) | 一种治疗闭经的中药组合物及其制备方法 | |
| CN102988639A (zh) | 一种治疗颈椎病的药物及其制备方法 | |
| CN104826074A (zh) | 一种用于窦性心动过缓的中药制剂及其制备方法 | |
| CN104857455A (zh) | 一种用于慢性间质性肾病中药制剂及其制备方法 | |
| CN101125189B (zh) | 一种治疗肾病的中药及其制备方法 | |
| CN103920058A (zh) | 一种治疗头痛的中药制剂及其制备方法 | |
| CN102755516B (zh) | 抑制艾滋病病毒的中药制剂及其制备方法 | |
| CN102600414B (zh) | 一种治疗颈椎病的中药组合物 | |
| CN106362120A (zh) | 一种治疗高血糖和糖尿病的中药方剂 | |
| CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
| CN104888042A (zh) | 一种用于产后恶露不绝病的中药制剂及其制备方法 | |
| CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
| CN104367984A (zh) | 一种治疗老年冠心病的中药组方 | |
| CN104623532A (zh) | 一种治疗脑胶质瘤的中药组合物及其制备方法 | |
| CN104840891A (zh) | 一种用于酒精性心肌病的中药制剂及其制备方法 | |
| CN104547369A (zh) | 一种治疗眼睑痉挛的内服药物及其制备方法 | |
| CN102988890A (zh) | 治疗黄褐斑的纯中药制剂 | |
| CN103784720A (zh) | 一种降血糖尿糖的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151028 |